Zimmer Biomet Holdings Inc NYSEZBH shares trading lower by $16.50 at $106.55 in Monday's session. After an inline Q3 report, the issue is being punished for its lowered FY 2016 EPS and sales guidance.
The issue, which made its all-time high ($131.25) and closing high ($131) on October 7, is now much closer to the $100 level.
After falling sharply in pre-market trading, it did manage a $1+ bounce off the open to $108 before resuming is downward course.
So far, its has reached $103.93 and has staged a rebound to the $106 area. That low corresponds with a series of seven lows it made in the $103 handle from March 18 to March 29.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.